AMLN Amylin Pharmaceuticals, Inc. (MM)

Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) will be presenting at the JPMorgan Healthcare Conference on Monday, January 10, 2005 at 9:00 a.m. Pacific Time in San Francisco, California. Ginger L. Graham, President and Chief Executive Officer of Amylin Pharmaceuticals will be providing a corporate overview, which will include a review of the company's development programs. The company will also participate in a webcast breakout session immediately following the presentation at 9:30 a.m. Pacific Time. Additionally, Amylin will be webcasting a discussion with investors from a separate event being held in conjunction with the JPMorgan conference at 7:00 p.m. Pacific Time on Tuesday, January 11, 2005. The presentations and the breakout session will be webcast separately, and recordings will be made available following each event. The webcasts and the recordings will be accessible through Amylin's corporate website, located at http://www.amylin.com/. To access the live webcasts, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software. Amylin Pharmaceuticals is committed to improving the lives of people with diabetes and other metabolic diseases through the discovery, development and commercialization of innovative, cost-effective medicines. DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Mark G. Foletta, Vice President of Finance and Chief Financial Officer of Amylin Pharmaceuticals, Inc., +1-858-552-2200 Web site: http://www.amylin.com/

Copyright